Ribozymes and deoxyribozymes in targeted cancer therapy / 国际肿瘤学杂志
Journal of International Oncology
; (12): 889-892, 2010.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-385523
Biblioteca responsável:
WPRO
ABSTRACT
In recent years, with the introduction of novel vectors capable of highly efficient transduction ,ribozymes and dexyribozymes have been become an ideal approach to anticancer therapy due to their high efficiency and lack of severe adverse effects. As many high efficiency targets have been found for cancer therapy, targeted therapy using ribozymes and deoxyribozymes may have multiple effects such as induction of tumor apoptosis and inhibition of tumor growth, metastasis, and angiogenesis.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of International Oncology
Ano de publicação:
2010
Tipo de documento:
Artigo